期刊文献+

易栓性疾病患者血浆中凝血因子V基因三种多态性和APC—R、LA的检测 被引量:1

The analysis of coagulation factor V G1691→A, G1091→G gene polymorphism, APC-R and LA in patients with thrombophilia
暂未订购
导出
摘要 目的 了解易栓性疾病患者凝血因子Ⅴ基因三种多态性和狼疮抗凝物质(LA)、活化蛋白C抵抗(APC-R)的发生率。方法 测定237例易栓性疾病(包括90例脑梗塞、59例冠心病、57例高血压、31例深静脉血栓)患者和正常对照血浆中LA、APC-R,并用限制性内切酶片段多态性方法测定FV G1691→A、C1091→C、A1090→G三种基因多态性的发生情况。结果 脑梗塞组LA阳性者有41例(45.6%),APC-R阳性者3例(3.3%);冠心病组LA阳性者有24例(40.7%),APC-R未见阳性;高血压组LA阳性者有22例(38.6%),APC-R阳性者有4例(7.0%);深静脉血栓组LA阳性者有13例(41.9%),APC-R阳性者1例(3.2%);对照组未见阳性、三种基因多态性都未见阳性。结论 易栓性疾病患者LA阳性率明显高于正常对照,LA可能是引起易栓性疾病患者血栓形成的重要原因之一,易栓性疾病患者存在APC—R,但可能和凝血因子Ⅴ基因三种多态性无关。 Objective To evaluate the incidence of gene polymorphism of coagulation factor V and activated protein C-resistance(APC-R)and lupus anticoagulant (LA) in patients with thrombophilia. Methods APC-R, LA and FV G1691→G, A1090→G gene polymorphism were assasyed in 237 patients with thrombophilia and 60 nor- mal subjects. Results There were 41 positive for LA (45.6%), 3 positive for APC-R(3.3%)in patients with Cere- bral infarct; 24 positive for LA(40.7%), 0 positive for APC-R in patients with Coronary heart disease; 22 posi- tive for LA (38.6%), 4 positive for APC-R(7.0%) in patients with high blood pressure; 13 positive for LA (41.9%), 1 positive for APC-R (3.2%), in patients with deep vein thrombosis. There were no positive for LA and APC-R in the control subjects. There were no FV G1691→A, G1091→C, A1090→G gene mutation in pa- tients with thrombophilia. Conclusion There were especially high positive LA rate and perhaps LA is one of the important causes of thrombosis in patients with thrombophilia. There were APC-R phenomenon in patients with thrombophilia, perhaps having no relationship with factor V gene mutation.
出处 《海南医学》 CAS 2004年第6期35-36,24,共3页 Hainan Medical Journal
关键词 易栓性疾病 血浆 凝血因子V 基因多态性 APC-R LA 狼疮抗凝物质 活化蛋白C抵抗 Cerebral infact Coronary heart disease High blood pressure Deep vein thrombosis Coagulation factor V Lupus anticoasgulant Gene polymorphism Activated protein C-resistance
  • 相关文献

参考文献7

  • 1Potzsch B, Kawamuraw H, Preissner KT,et al. Acquired protein C dysfunction but not decreased activity of TM is a possible mawrker of thrombophilia in patientsx with lupus anticoawgulawnts[J]. Lab Clin Med, 1995,125:56.
  • 2Dahlback B,Carlson M,Srensson PJ, et al.Familial, thrombophilia due to a previously unrecognized mechanism, characterized by poor anticoagulant response to activated protein C [J]. Proc Natl Acad Sci USA, 1993,90: 1004- 1007.
  • 3Lechner K, Pahinger-Fasching I . upus anticoawgulant and thrombosis[J]. Haemostawsis, 1985,15:254.
  • 4Rees DC,Cox M , Clegg JB. World distribution of factor V Leiden Lancet, 1995,346:1133-1140.
  • 5Ehernforth S Radtke KP, Scharrer I, et al. Acquired activated protein C-resistance in patients with lupus anticoagulants[J]. Thromb Haemost,1994,71:160.
  • 6屈晨雪,夏铁安,王建中.血栓病患者凝血、抗凝和纤溶活性改变的研究[J].中国实验诊断学,2001,5(5):222-224. 被引量:12
  • 7白春梅,潘家绮,李秀荣,范连凯.静脉血栓患者和正常人凝血因子V Leiden和凝血酶原基因G20210A变异的研究[J].中华医学杂志,1999,79(12):900-902. 被引量:19

二级参考文献3

共引文献29

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部